Understanding relapse factors in alcohol use disorder

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to identify risk factors associated with relapse in patients suffering from alcohol use disorder (AUD). It will explore whether there are distinct clusters of patients with similar characteristics and outcomes, and which risk factors are most predictive of relapse within these clusters. Participants will complete self-administered questionnaires, undergo evaluations by others, and participate in an electrophysiological assessment. The study also investigates the potential utility of a feedback measurement system in a detoxification unit.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* To suffer from AUD
* To be hospitalized
* To speak French fluently
* To be able to give their consent (medically and legally).

Exclusion Criteria:

* To suffer from severe perceptive disabilities (auditory, visual)
* To suffer from severe cognitive impairment

Where it's running

• Cliniques Universitaires Saint-Luc
  Brussels, Brussels Capital, Belgium Recruiting

Study contacts

• Principal investigator: Philippe de Timary, PhD — Université catholique de Louvain (Wallonia)
• Study coordinator: Claire Emmanuèle Marie Ledouble
• Email: claireledouble@hotmail.com
• Phone: +32474731113

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures

  This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.

  Recruiting Université Catholique de Louvain · Brussels, Belgium · NCT07925281

• Thiamine to reduce brain injury in adults with alcohol use disorder

  This trial tests whether thiamine can help protect the brain in adults with moderate to severe alcohol use disorder who drink daily.

  Recruiting Phase 2 Institut National de la Santé Et de la Recherche Médicale, France · Paris, Île-de-France Region · NCT07844720

• Digital Recovery Support for Black adults with Alcohol Use Disorder in Detroit

  This study tests whether a smartphone-based digital recovery program helps Black or African American adults in Detroit maintain their recovery from alcohol use disorder.

  Recruiting Brandeis University · Detroit, Michigan · NCT07724275

• Path180: a computer-based skills program to help teens reduce alcohol use

  This 8-week trial tests Path180, a computer-based skills training, added to usual care for teens 13–19 with alcohol use disorder to see if it improves daily-life coping skills and outcomes.

  Recruiting Brown University · Providence, Rhode Island · NCT07713251

• Effects of comorbidity on people with severe mental illness

  This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.

  Recruiting Abant Izzet Baysal University · Bolu, Bolu · NCT07692984

• Psilocybin in Alcohol Use Disorder with Depression (Relapse Prevention)

  This study tests whether higher-dose psilocybin-assisted psychotherapy helps prevent relapse in adults with severe alcohol use disorder and depressive symptoms after detox.

  Recruiting Phase 3 Centre Hospitalier Universitaire de Nīmes · Bayonne and 7 other locations · NCT07638553

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.